Buprenorphine FAQ and Peer Discussion
Frequently asked questions about buprenorphine care; chapter in the Integration of Buprenorphine into HIV Primary Care document.
Frequently asked questions about buprenorphine care; chapter in the Integration of Buprenorphine into HIV Primary Care document.
This page is a collection of all the written Q&A summary documents from webinars co-hosted by the DISQ Team and RWHAP Data Support. If you have any additional questions about the content covered here, please contact DISQ via our TA Request Form or DISQ email account.
Resource updated 06/05/2024
U.S. HIV-related treatment guidelines, drug database, and glossary.
Resource updated 09/20/2023
Help with the RSR, ADR, CDR, EHE, HIVQM, and AETC data systems. Project period: 2020-2025.
RWHAP Technical Assistance Provider updated on 04/15/2024
Help with HRSA Electronic Handbooks (EHB) - 877-464-4772 - 8am-8pm ET, M-F - Contact HRSA About the EHB
RWHAP Technical Assistance Provider updated on 04/15/2024
RWHAP Technical Assistance Provider updated on 04/15/2024
Healthcare providers can receive no-cost expert clinical consultation in HIV prevention & care, HCV treatment, and substance use management.
Resource updated 09/20/2023
HIV clinical training resources for HRSA's AIDS Education and Training Centers Program.
Resource updated 04/17/2024
Tool for service and program monitoring.
Resource updated 09/19/2023
Tool for service and program monitoring.
Resource updated 09/19/2023